Johnson & Johnson Impact Ventures
VC Fund
Johnson & Johnson Impact Ventures is a VC fund focused on Health Care and Medical. Johnson & Johnson Impact Ventures invest in purpose-driven entrepreneurs innovating at the front lines of care.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Johnson & Johnson Impact Ventures invests in
Stages Johnson & Johnson Impact Ventures invests in
Countries Johnson & Johnson Impact Ventures invests in
Investment Focus
Industry
- Health Care 6 (86%)
- Medical 3 (43%)
- Women's 1 (14%)
- mHealth 1 (14%)
- Big Data 1 (14%)
Stage
- Seed 3 (43%)
- Funding Round 2 (29%)
- Series A 1 (14%)
- Series B 1 (14%)
Country
- United States 2 (29%)
- Egypt 1 (14%)
- Mexico 1 (14%)
- Singapore 1 (14%)
- South Africa 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rology
|
AI-assisted On-demand Teleradiology Platform | Dec 01, 2025 | |
CareLoop Health
|
CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms. | $2.2M / Seed / Jan 30, 2025 | |
Hamilton Health Box
|
Hamilton Health Box is an onsite direct primary and urgent care microclinic operator for the self-insured employer. It makes healthcare accessible, convenient, and affordable, making sure to get the care where needs it when needed it.Their team of healthcare professionals is shepherds for businesses and their employee population, with a team ofdedicated providers caring for employees and their families. | $10M / Series A / May 14, 2024 | |
Health In Her HUE
|
Health In Her HUE is a digital platform that connects Black women to Black and culturally competent healthcare providers, and offers evidence-based health content that centers Black women’s lived experiences. We strive to reduce racial health disparities by leveraging the power of technology, media and community to improve health outcomes for Blackwomen. | $3M / Seed / Jan 08, 2024 | |
54 Collective
|
Building and scaling African tech startups with catalytic capital, value-add support and our global network. | $114M / Aug 16, 2023 | |
Mamotest
|
Mamotest is a data-driven patient end-to-end solution defeating breast cancer. It goes from awareness and high-quality imaging diagnosis to patient journey follow-up. We collect medical and clinical data and care for psychological and socio-economic data. That broader scope with 100% patient traceability allows us to put vital information in thehands of global business and policy decision-makers, giving them the power to save hundreds of thousands of women's lives. | $3.3M / Seed / Mar 27, 2023 | |
SwipeRx
|
mClinica develops mobile platforms that strengthen the pharmaceutical supply chain, generate data, improve patient adherence to medication, and build the capacity of the pharmacy workforce. Since 2017, mClinica has connected 150,000 pharmacy professionals and 40,000 pharmacies through a single digital channel. Their users reach approximately 150million patients each month. mClinica currently operates across Indonesia, Philippines, Vietnam, Cambodia, Thailand, Malaysia, and Singapore with capacity for expansion. Their team is composed of over 120 team members including experts in public health, data science, and pharmacy. mClinica is supported by impact investors like the Global Innovation Fund (backed by USAID, UKAID, DFAT, Swedish Government, and the Omidyar Network) and Patamar Capital (formerly Unitus Impact) as well as other investors from the US, Europe, and Asia. mClinica implements projects both digitally and on the ground to connect the world’s pharmacies and transform global health. mClinica follows a social enterprise business model in which they seek double-bottom line returns – maximizing both financial returns and social impact.mClinica’s rapid growth and success is increasingly recognized. mClinica was the recipient of the Data Driven Apps Award of the World Government Summit in 2019, USAID-FHI360 Data for Resilience Award, Pierre Fabre Foundation Prize for eHealth Innovation, and Hack Osaka. The company has consistently been recognized as one of the most innovative startups in healthcare in Asia Pacific. | $27M / Series B / May 23, 2022 |
Co-Investors
MDI Ventures
2 deals together
Bill & Melinda Gates Foundation
1 deal together
Genius Guild
1 deal together
HBCU Founders Accelerator
1 deal together
Memorial Hermann Health System
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Johnson & Johnson Impact Ventures invest in?
Johnson & Johnson Impact Ventures invests primarily in Health Care, Medical and Women's startups, most often at Seed and Funding Round stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Johnson & Johnson Impact Ventures last invest?
The most recent investment recorded for Johnson & Johnson Impact Ventures closed in Dec 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
